Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Bioequivalence of ZolpiMist compared with zolpidem tablets.

Trial Profile

Bioequivalence of ZolpiMist compared with zolpidem tablets.

Completed
Phase of Trial: Phase II

Latest Information Update: 05 Feb 2011

At a glance

  • Drugs Zolpidem (Primary)
  • Indications Insomnia; Sleep disorders
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics; Registrational
  • Most Recent Events

    • 05 Feb 2011 Zolpimist Oral Spray launched in the US, according to a NovaDel media release.
    • 05 Feb 2011 ECR Pharmaceuticals Co., a subsidiary of Hi-Tech Pharmacal Co., announced the immediate availability of Zolpimist Oral Spray n the US, in a media release.
    • 24 Jan 2008 Status change from initiated to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top